Cargando…

Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats

Atherosclerosis remains the number one cause of death and disability worldwide. Atherosclerosis is treated by revascularization procedures to restore blood flow to distal tissue, but these procedures often fail due to restenosis secondary to neointimal hyperplasia. Diabetes mellitus is a metabolic d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buglak, Nicholas E., Jiang, Wulin, Bahnson, Edward S.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122148/ https://www.ncbi.nlm.nih.gov/pubmed/30172101 http://dx.doi.org/10.1016/j.redox.2018.08.013

Ejemplares similares

Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022)

Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia
por: Shan, Dan, et al.
Publicado: (2022)

Delivery of Cinnamic Aldehyde Antioxidant Response Activating nanoParticles (ARAPas) for Vascular Applications
por: Cartaya, Ana E., et al.
Publicado: (2021)

Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation
por: Wu, Wen, et al.
Publicado: (2019)

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014)

Viscolin Inhibits In Vitro Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia In Vivo
por: Chen, Chin-Chuan, et al.
Publicado: (2016)

Chemerin Stimulates Vascular Smooth Muscle Cell Proliferation and Carotid Neointimal Hyperplasia by Activating Mitogen-Activated Protein Kinase Signaling
por: Xiong, Wei, et al.
Publicado: (2016)

Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice
por: Zhang, Shunchi, et al.
Publicado: (2022)

Adropin inhibits the phenotypic modulation and proliferation of vascular smooth muscle cells during neointimal hyperplasia by activating the AMPK/ACC signaling pathway
por: Wang, Li, et al.
Publicado: (2021)

Mebendazole Reduces Vascular Smooth Muscle Cell Proliferation and Neointimal Formation Following Vascular Injury in Mice
por: Wang, Jintao, et al.
Publicado: (2014)

Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation, migration and neointimal hyperplasia through PI3K/Akt signaling
por: Fang, Haihong, et al.
Publicado: (2018)

Bone marrow-derived mesenchymal stem cells inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia after arterial injury in rats
por: Iso, Yoshitaka, et al.
Publicado: (2018)

Deletion of Smooth Muscle Lethal Giant Larvae 1 Promotes Neointimal Hyperplasia in Mice
por: Zhang, Ya, et al.
Publicado: (2022)

Lithium Chloride Inhibits Vascular Smooth Muscle Cell Proliferation and Migration and Alleviates Injury-Induced Neointimal Hyperplasia via Induction of PGC-1α
por: Wang, Zhuyao, et al.
Publicado: (2013)

All-Trans-Retinoic Acid Suppresses Neointimal Hyperplasia and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration via Activation of AMPK Signaling Pathway
por: Zhang, Jingzhi, et al.
Publicado: (2019)

Jujuboside B Inhibits Neointimal Hyperplasia and Prevents Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration via Activation of AMPK/PPAR-γ Signaling
por: Ji, Zaixiong, et al.
Publicado: (2021)

Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by K(V)1.3 channel blockers
por: Cheong, Alex, et al.
Publicado: (2011)

Smooth muscle cell‐specific Tgfbr1 deficiency attenuates neointimal hyperplasia but promotes an undesired vascular phenotype for injured arteries
por: Liao, Mingmei, et al.
Publicado: (2016)

Role of hsa_circ_0000280 in regulating vascular smooth muscle cell function and attenuating neointimal hyperplasia via ELAVL1
por: Wang, Zunzhe, et al.
Publicado: (2022)

MicroRNA-26a targets MAPK6 to inhibit smooth muscle cell proliferation and vein graft neointimal hyperplasia
por: Tan, Juanjuan, et al.
Publicado: (2017)

Curcumin inhibits proliferation, migration and neointimal formation of vascular smooth muscle via activating miR-22
por: Zhang, Minghua, et al.
Publicado: (2020)

A vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia
por: Serrano, Ramon L., et al.
Publicado: (2019)

Downregulation of Cavin‐1 Expression via Increasing Caveolin‐1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury–Induced Neointimal Hyperplasia
por: Zhou, Li‐Jun, et al.
Publicado: (2017)

The New Weapon to Inhibit Proliferation and Migration of Smooth Muscle Cell in Neointimal Formation
por: Chae, Cheong-Whan, et al.
Publicado: (2020)

Vanin-1 Pantetheinase Drives Smooth Muscle Cell Activation in Post-Arterial Injury Neointimal Hyperplasia
por: Dammanahalli, K. Jagadeesha, et al.
Publicado: (2012)

MicroRNA-320 targeting neuropilin 1 inhibits proliferation and migration of vascular smooth muscle cells and neointimal formation
por: Li, Hongqiang, et al.
Publicado: (2019)

MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2
por: Feng, Shengdong, et al.
Publicado: (2019)

PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury
por: Yang, Han-Mo, et al.
Publicado: (2013)

Thymoquinone suppresses platelet‐derived growth factor‐BB–induced vascular smooth muscle cell proliferation, migration and neointimal formation
por: Zhu, Ning, et al.
Publicado: (2019)

Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling
por: Miller, Eileen, et al.
Publicado: (2017)

Notch Signaling in Endothelial Cells: Is It the Therapeutic Target for Vascular Neointimal Hyperplasia?
por: Tian, Ding-Yuan, et al.
Publicado: (2017)

Wood-Derived Vascular Patches Loaded With Rapamycin Inhibit Neointimal Hyperplasia
por: Xie, Boao, et al.
Publicado: (2022)

CFTR Suppresses Neointimal Formation Through Attenuating Proliferation and Migration of Aortic Smooth Muscle Cells
por: Lu, Liu-Yi, et al.
Publicado: (2022)

Inhibition of lysine‐specific demethylase 1A suppresses neointimal hyperplasia by targeting bone morphogenetic protein 2 and mediating vascular smooth muscle cell phenotype
por: Zhang, Xiaobo, et al.
Publicado: (2019)

Mechanisms for Improving Hepatic Glucolipid Metabolism by Cinnamic Acid and Cinnamic Aldehyde: An Insight Provided by Multi-Omics
por: Wu, You, et al.
Publicado: (2022)

Different Responses of Neointimal Cells to Imatinib Mesylate and Rapamycin Compared with Normal Vascular Smooth Muscle Cells
por: Park, Yang Jin, et al.
Publicado: (2014)

Vascular smooth muscle cells in intimal hyperplasia, an update
por: Déglise, Sébastien, et al.
Publicado: (2023)

Age-related changes in monocytes exacerbate neointimal hyperplasia after vascular injury
por: Martinez, Laisel, et al.
Publicado: (2015)

Semaphorin-3A protects against neointimal hyperplasia after vascular injury
por: Wu, Jie-hong, et al.
Publicado: (2018)

Lysophosphatidic acid enhances neointimal hyperplasia following vascular injury through modulating proliferation, autophagy, inflammation and oxidative stress
por: Shen, Xuhui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e488b4ltrq5j8s52javcd2slq0